In line with our findings, an association between poor treatment outcome and GRP78 overexpression was also found in various other tumor types including pancreatic cancer (33), ureter cancer (34), and esophageal carcinoma (35). This evidence concerns the gene HSPA5 and pancreatic neoplasm.